Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), Ashok Alco Chem has informed that the Board of Directors of the Company at its Meeting held on December 16, 2019 has approved the acquisition of 35,000 equity shares of Aeon Procare (Aeon) from the existing shareholders of Aeon, thereby making it a wholly-owned subsidiary of the Company.
The above information is a part of company’s filings submitted to BSE.
